Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Recent Advances in the Development of Small-Molecular Inhibitors Target HIV Integrase-LEDGF/p75 Interaction

Author(s): Yu Zhao and Zaigang Luo

Volume 15, Issue 14, 2015

Page: [1195 - 1208] Pages: 14

DOI: 10.2174/1389557515666150709114917

Price: $65

Abstract

Lens epithelium-derived growth factor (LEDGF/p75) plays an essential role in the HIV-1 replication. It acts by tethering integrase (IN) into the host cellular chromatin. Due to its significance of the IN-LEDGF/p75 interaction affords a novel therapeutic approach for the design of new classes of antiretroviral agents. To date, many small molecules have been found to be the inhibitors of INLEDGF/ p75 interaction. This review summarizes recent advances in the development of potential structure-based IN-LEDGF/p75 interaction inhibitors. The work will be helpful to shed light on the antiretroviral drug development pipeline in the next future.

Keywords: HIV-1; integrase; LEDGF/p75; integrase-LEDGF/p75 interaction inhibitors .


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy